4L0V image
Deposition Date 2013-06-01
Release Date 2013-10-30
Last Version Date 2023-09-20
Entry Detail
PDB ID:
4L0V
Title:
Tankyrase 2 in complex with 4'-chloro flavone
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.70 Å
R-Value Free:
0.20
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
C 2 2 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Tankyrase-2
Gene (Uniprot):TNKS2
Chain IDs:A, C (auth: B)
Chain Length:191
Number of Molecules:2
Biological Source:Homo sapiens
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Tankyrase-2
Gene (Uniprot):TNKS2
Chain IDs:B (auth: C), D
Chain Length:49
Number of Molecules:2
Biological Source:Homo sapiens
Primary Citation
Discovery of tankyrase inhibiting flavones with increased potency and isoenzyme selectivity.
J.Med.Chem. 56 7880 7889 (2013)
PMID: 24116873 DOI: 10.1021/jm401463y

Abstact

Tankyrases are ADP-ribosyltransferases that play key roles in various cellular pathways, including the regulation of cell proliferation, and thus, they are promising drug targets for the treatment of cancer. Flavones have been shown to inhibit tankyrases and we report here the discovery of more potent and selective flavone derivatives. Commercially available flavones with single substitutions were used for structure-activity relationship studies, and cocrystal structures of the 18 hit compounds were analyzed to explain their potency and selectivity. The most potent inhibitors were also tested in a cell-based assay, which demonstrated that they effectively antagonize Wnt signaling. To assess selectivity, they were further tested against a panel of homologous human ADP-ribosyltransferases. The most effective compound, 22 (MN-64), showed 6 nM potency against tankyrase 1, isoenzyme selectivity, and Wnt signaling inhibition. This work forms a basis for rational development of flavones as tankyrase inhibitors and guides the development of other structurally related inhibitors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures